Research

Hormonal

The PA-GLP1 formulation resulted in an overall reduction in blood glucose levels and reduced weight gain compared to daily injections of semaglutide.

This formulation may be more effective than current daily treatments for diabetes.

StrongSupportsmedium confidence
Achieved sustained serum concentrations for at least 40 days, with an overall reduction in blood glucose levels and reduced weight gain, comparing favorably to daily injections of semaglutide.
Weike Chen et al. · ACS Nano · 2024

Why this rating

Based on direct comparison with an established treatment.

Source

Engineering Supramolecular Nanofiber Depots from a Glucagon-Like Peptide-1 Therapeutic

Weike Chen et al. · ACS Nano · 2024

DOI 10.1021/acsnano.4c10248

otherCited 6×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →